Pharmacokinetics of heparin and its pharmacodynamic effect on plasma lipoprotein lipase activity and coagulation in healthy horses.
We evaluated the pharmacokinetics of IV administered sodium heparin and the pharmacodynamic effect of heparin on lipoprotein lipase (LPL) activity. Horses were allotted to 3 groups. Plasma samples were obtained from each horse before and at various times for 6 hours after heparin administration for determination of heparin concentration, LPL activity, and activated partial thromboplastin time (APTT). The disposition of heparin was dose dependent. The area under the plasma heparin concentration vs time curve (AUC) increased more than proportionally with dose, indicating that heparin elimination was nonlinear. Total clearance of heparin was similar after the 40 and 80 IU/kg of body weight dosages, averaging 0.45 and 0.36 IU/kg/min, respectively. However, after administration of the 120 IU/kg dose, clearance was significantly less than that after the 40 IU/kg dose. The half-life of heparin averaged 53, 70, and 136 minutes after 40, 80, and 120 IU/kg, respectively, with significant differences observed between the low and high doses. In contrast to heparin, the area under the plasma concentration vs time curve for LPL activity increased less than proportionally with dose. Maximal LPL activity observed was independent of dose, averaging 4.8 mumol of free fatty acids/ml/h. The APTT was significantly prolonged for 120 minutes after administration of the 40 IU/kg dose. Correlation coefficients for LPL activity vs either plasma heparin concentration or APTT were less than 0.7, indicating that neither laboratory measure can be used to accurately predict plasma LPL activity.
McCann
M E
ME
Department of Physiology/Pharmacology, College of Veterinary Medicine, University of Georgia, Athens 30602, USA.
Watson
T D
TD
Boudinot
F D
FD
Moore
J N
JN
D000704:Analysis of Variance; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006493:Heparin / Q000493:pharmacokinetics* / Q000494:pharmacology*; D006736:Horses / Q000097:blood / Q000378:metabolism; D008071:Lipoprotein Lipase / Q000097:blood / Q000187:drug effects*; D008297:Male; D010314:Partial Thromboplastin Time / Q000662:veterinary
D006493:Heparin; D008071:Lipoprotein Lipase